/
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation - PowerPoint Presentation

cheryl-pisano
cheryl-pisano . @cheryl-pisano
Follow
351 views
Uploaded On 2018-12-11

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation - PPT Presentation

Location of Centers Participating in the CIBMTR 2015 Annual Number of Transplant Recipients in the US by Transplant Type Allogeneic Transplant Recipients in the US by Donor Type Cumulative Plot of Transplant Recipients in the US by Transplant Type ID: 740023

2013 transplants 2003 survival transplants 2013 survival 2003 donor allogeneic years sibling match hla age lymphoma unrelated autologous cell

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Current Uses and Outcomes of Hematopoiet..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Current Uses and Outcomes of Hematopoietic Stem Cell TransplantationSlide2

Location of Centers Participatingin the CIBMTR 2015Slide3

Annual Number of Transplant Recipients in the US by Transplant TypeSlide4

Allogeneic Transplant Recipients in the US, by Donor TypeSlide5

Cumulative Plot of Transplant Recipients in the US by Transplant TypeSlide6

HLA-Match Sibling Donor Allogeneic Transplants in Patients ≤20 YearsSlide7

Unrelated Donor Allogeneic Transplants in Patients ≤20 YearsSlide8

HLA-Match Sibling Donor Allogeneic Transplants in Patients Age >20 yearsSlide9

Unrelated Donor Allogeneic Transplants in Patients Age >20 yearsSlide10

Trends in Autologous Transplants by Recipient Age*Slide11

Trends in Allogeneic Transplants by Recipient Age*Slide12

Indications for Hematopoietic Stem Cell Transplants in the US, 2013Slide13

Causes of Death after Autologous Transplants done in 2012-2013Slide14

Causes of Death after HLA Match Sibling Transplants done in 2012-2013Slide15

Causes of Death after Unrelated Donor Transplants done in 2012-2013Slide16

Allogeneic Transplants Registered with the CIBMTRSlide17

Survival after HLA Match Sibling Donor Transplants for AML, 2003-2013Slide18

Survival after Unrelated Donor Transplants for AML, 2003-2013Slide19

Survival after HLA Match Sibling Donor Transplants for AML, Age <20 Years, 2003-2013Slide20

Survival after Allogeneic Transplants for Myelodysplastic Syndrome (MDS), 2003-2013Slide21

Survival after Allogeneic Transplants for Myelodysplastic Syndrome (MDS), 2003-2013Slide22

Survival after HLA Match Sibling Donor Transplants for Myeloproliferative Diseases, 2003-2013Slide23

Survival after Unrelated Donor Transplants for

Myeloproliferative Diseases

, 2003-2013Slide24

Survival after HLA Match Sibling Donor Transplants for ALL, Age <20 Years, 2003-2013Slide25

Survival after Unrelated Donor Transplants for ALL, Age <20 years, 2003-2013Slide26

Survival after HLA Match Sibling Donor Transplants for ALL, Age ≥20 Years, 2003-2013Slide27

Survival after Unrelated Donor Transplants for ALL, ≥20 Years, 2003-2013Slide28

Survival after HLA Match Sibling Transplants for CML, 2003-2013Slide29

Survival after Allogeneic Transplants for Chronic Lymphocytic Leukemia (CLL), 2003-2013Slide30

Survival after Allogeneic Transplants for Severe Aplastic Anemia, <20 Years, 2003-2013Slide31

Survival after Allogeneic Transplants for Severe Aplastic Anemia, ≥20 Years, 2003-2013Slide32

Survival after Autologous Transplants for Hodgkin Lymphoma, 2003-2013Slide33

Survival after Allogeneic Transplants for Hodgkin Lymphoma, 2003-2013Slide34

Survival after Autologous Transplants for Follicular Lymphoma, 2003-2013Slide35

Survival after Allogeneic Transplants for Follicular Lymphoma, 2003-2013Slide36

Survival after Autologous Transplants for Diffuse Large B-cell Lymphoma (DLBCL), 2003-2013Slide37

Survival after HLA Match Sibling Transplants for Diffuse Large B-cell Lymphoma (DLBCL)

, 2003-2013Slide38

Survival after Transplants for Mantle Cell Lymphoma, 2003-2013Slide39

Survival after Transplants for Multiple Myeloma, 2003-2013Slide40

Survival after Autologous Transplants for Multiple Myeloma, 2000-2013